Head of the Gastroenterological Surgery Division of the Hosptial de Clinicas de Buenos Aires
Director of the Digestive Surgery Specialist Course. Buenos Aires' University
Associate Professor University of Buenos Aires
Member AAC, SACP and SBCP

Dr. Alessio Pigazzi, was appointed chief of colorectal surgery at NewYork-Presbyterian/Weill Cornell Medical Center and Weill Cornell Medicine, effective September 2020. He also serves on Weill Cornell Medicine's faculty. In this role, Dr. Pigazzi leads a world-class team of colorectal surgeons that uses state-of-the-art technologies and innovative surgical techniques to provide patients with the very best in comprehensive colorectal care.

I am a board-certified medical oncologist specializing in the treatment of patients with gastrointestinal (GI) cancers, particularly colorectal cancer (CRC), appendix cancer, and cholangiocarcinoma. My research is focused on the development of novel systemic and regional therapies, including approaches based on tumor genomics, with the goal of improving outcomes while minimizing treatment-related toxicities.
I am the founder and co-director of the Center for Young Onset Colorectal and Gastrointestinal Cancer. This clinic — the first of its kind in the world — is dedicated solely to the specific needs of people under 50 who have CRC or other GI cancers.

Physician-surgeon, specialist in general surgery, and with a supra-specialty in coloproctology (surgery of the colon, rectum and anus), with more than 30 years of experience, including minimally invasive techniques. He is a Fellow of the American College of Surgeons (FACS), and of the American College of Colon and Rectal Surgeons (FASCRS). Care is centered on the patient and their family, with the multidisciplinary support of the University Hospital of the Santa Fe de Bogotá Foundation. He is an institutional member of the Santa Fe de Bogotá Foundation since 1993, having held multiple positions such as Head of the Surgery Department, and Head of the Colon and Rectal Surgery Section (Coloproctology). He is a member of the C4 Clinical Care Center for Peritoneal Neoplasms that is certified by the Joint Commission International (JCI), unique in the world (Sugarbaker Surgery).

Professor Moeslein is Professor of Surgery and Dept. Head of the newly established Center for Hereditary Tumours at the Academic Hospital “Ev. Krankenhaus Bethesda“ of the University of Düsseldorf.
She completed her surgical training at the University of Heidelberg and Düsseldorf, interrupted by a 6 month stipend at the University of Hyogo, where she trained with Prof. Joji Utsonomiya. Further she completed her research year with a DFG-funded stipend to Mayo Clinic, Dept. of Molecular Genetics headed by Prof. Steve Thibodeau. From 2005 – 2015 she was Dept. Chair of the Surgical Department HELIOS St. Josefs-Klinik in Bochum, after which she initiated and chaired the Department for Hereditary Tumors in HELIOS Wuppertal, University of Witten-Herdecke. During this time she further specialized in the field of prophylactic surgery for hereditary conditions including the upper GI-tract, pouches and also continence surgery.
Prof. Moeslein has been a long-standing elected Council member and Director of InSiGHT (International Society for Hereditary Gastrointestinal Tumors). Together with Prof. H. Vasen she initiated the Mallorca Group as a European Expert Group on Hereditary Cancer, which has developed to become the European Hereditary Tumor Group, that she is currently chairing. She is external advisor for the CFR (Cancer Family Registries) and is a founding member of the IMRC (International Mismatch Repair Consortium). She is also a founding member of the German Consortium for HNPCC and Steering Committee member. She has been the secretary of ESCP (European Society of Coloproctology) since 2017. She is member of the editorial board of Colorectal Disease and Hereditary Cancer. Her research activities focus on prophylactic surgery for hereditary conditions, ileoanal and continent pouches and chemoprevention. She focusses on promoting and enabling collaborative studies and networking.

Present Title & Affiliation
Primary Appointment
Department Chair ad interim, Department of Colon and Rectal Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
Professor, Department of Colon and Rectal Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
Associate Vice President, Regional Surgery Strategy, The University of Texas MD Anderson Cancer Center, Houston, TX

Dr. Giovanna da Silva is a colorectal surgeon at Cleveland Clinic Florida and holds academic appointment as Associate Professor at Ross medical school. She completed general and colorectal surgery training in Brazil, in 1999. She was a research fellow at Cleveland Clinic Florida from 2000 to 2004, after which she did general surgery residency at Mount Sinai School of Medicine and Maimonides Medical Center, in NY from 2004 to 2009. She did her colorectal surgery fellowship at Cleveland Clinic Florida in 2009. Dr. da Silva was clinical associate in the Department of Colorectal Surgery in 2010, and has been on staff since 2011. Dr. da Silva is currently the Director of Clinical Research of the Department of Colorectal Surgery at Cleveland Clinic Florida and Co-director of Hereditary Colorectal Cancer and Polyposis Center.

MD, MPH, MBA, FACS, FASCRS
Roscoe Bennett Gray Cowper, MD, Distinguished Professor
Chief of the Gastrointestinal Surgery Division
UNC-Chapel Hill
Clinical Reserach

Cirurgia Colorretal
Memorial Sloan Kettering Cancer Center e New York-Presbyterian Hospital
Câncer colorretal, doença inflamatória Intestinal, Cirurgia minimamente invasiva e cirurgia robótica.

Dr. Paul Hendrick Sugarbaker was born in Baltimore (MD, USA). His college education took place at Wheaton College in Illinois. He graduated from Cornell University Medical College in New York (USA) and from there went for his surgical training at the Peter Bent Brigham Hospital in Boston (MA, USA), now known as Brigham and Women’s Hospital. He received a Master’s Degree in Immunology at the Harvard School of Arts and Sciences in 1983. At the NIH he was a Senior Investigator from 1976 to 1986. After 3 years in Atlanta at the Emory Clinic he moved back to Washington (DC, USA) to become the Medical Director of the Washington Cancer Institute. He has been at the Washington Cancer Institute since 1989. He was the Director for the Program in Peritoneal Surface Malignancy from 1989-2020. His interests are in gastrointestinal cancer, gynecologic malignancy and mesothelioma. Much of his early clinical research focused on liver metastases. Currently, his clinical and investigative work is directed at the peritoneal surface component of gastrointestinal and gynecologic cancer dissemination, referred to as peritoneal metastases. Dr. Sugarbaker is a strong critic of surgical tradition; he believes that major changes in the technology of cancer resection are necessary. His theme, ‘It’s what the surgeon doesn’t see that kills the patient’, summarizes the concepts behind many of his publications both in the peer-reviewed medical literature and in the lay press. In the opinion of Dr Sugarbaker, perioperative intravenous and intraperitoneal chemotherapy are an essential planned part of many cancer interventions.

Scott R. Steele MD, MBA is the President of Main Campus at the Cleveland Clinic in Cleveland, Ohio. He is also the Rupert B. Turnbull MD Endowed Chair in Colorectal Surgery and Chairman of Colorectal Surgery at Cleveland Clinic in Cleveland, OH. A graduate of the United States Military Academy at West Point, NY, he was an active-duty Army officer for over 20 years, serving as the Chief of Colorectal Surgery at Madigan Army Medical Center, Fort Lewis, WA. He has served 4 combat tours in Iraq and Afghanistan, being awarded the Bronze Star and Combat Medical Badge, amongst others. He is on the editorial board for multiple national surgical journals including Annals of Surgery, Cochrane Collaboration, and had served as the Colon & Rectal Surgery Community Editor for the American College of Surgeons. He is also an Editor for Surgery, Co-Editor for Diseases of the Colon & Rectum, and the Editor-in-Chief for Clinics in Colon and Rectal Surgery. Additionally, he is a reviewer for over 30 peer-reviewed journals. He has also been appointed to the American Board of Colon and Rectal Surgery for the last several years, and currently serves as the Past-President. His contributions to the medical literature include over 350 peer-reviewed articles, 110 invited reviews and book chapters, 30 national practice parameters, guest editor for 5 volumes dedicated to colorectal disease, and currently is an editor on 12 textbooks in colorectal surgery. He also received his MBA from Case Western University Weatherhead School of Business and Management in 2018, graduating with honors.

Director, Ellen Leifer Shulman & Steven Shulman Digestive Disease Center / Department Chair, Colorectal Surgery Cleveland Clinic Florida, Weston